蛋白合成和他类药物的副作用
Bernd Moosmann1, Christian Behl
1Department of Pathobiochemistry, Johannes Gutenberg University, Medical School, Mainz, Germany.
Lancet (London, England)
|March 20, 2004
概括
对于高胆固醇有效的他类药物可能会通过干扰代谢而导致肌肉损伤. 这项研究表明,他类药物的副作用与缺乏途径之间存在联系,这可能解释肌肉病变.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 类药物是高胆固醇血症和冠状动脉心脏病的首要治疗方法.
- 不同寻常的副作用,如肌肉病变和多神经病变可能会发生在他类药物使用.
- 立方体的副作用与缺乏症中观察到的病理有相似之处.
研究的目的:
- 为了研究他类药物使用和代谢之间的生物化学联系.
- 为了探索他类药物对蛋白合成产生负面影响的假设.
- 确定这种途径是否解释了他类药物诱导的肌肉病变.
主要方法:
- 对已确定的生化途径进行审查.
- 对单半氨酸-tRNA (([Ser]Sec) 的异乙烯化分析.
- 将他类药物的副作用与缺乏症症状进行比较.
主要成果:
- 类他类药物可能会抑制单半氨酸-tRNA的异乙烯化 (([Ser]Sec).
- 这种抑制可以导致减少蛋白合成.
- 观察到的效应与缺乏已知的后果一致.
结论:
- 斯坦丁对蛋白合成的负面影响为其副作用提供了潜在的解释.
- 这种机制对于理解他类药物诱导的肌肉病变可能特别重要.
- 对在他类药物治疗中的作用进行进一步研究是有必要的.
相关概念视频
Combined Effects of Drugs: Antagonism
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Factors Affecting Protein-Drug Binding: Drug Interactions
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...


